Tag: #MultipleMyeloma
-
Elderly Multiple Myeloma Patients Benefit Equally from Stem Cell Transplantation: A New Perspective
Introduction Multiple Myeloma (MM) is a plasma cell malignancy affecting millions worldwide. While autologous hematopoietic stem cell transplantation (AHSCT) is a standard treatment for eligible patients, concerns remain regarding its effectiveness in elderly individuals. However, new research suggests that patients over 70 years of age benefit equally from AHSCT compared to younger counterparts. Visit https://www.stemcelltherjournal.com/jsctt…
-
Autologous Hematopoietic Stem Cell Transplantation: Insights from King Fahad Specialist Hospital’s Experience
Introduction: Autologous hematopoietic stem cell transplantation (HSCT) remains a cornerstone in treating multiple myeloma, offering improved survival outcomes. A recent study from King Fahad Specialist Hospital in Dammam, Saudi Arabia, explores the efficacy and safety of HSCT using both cryopreserved and non-cryopreserved stem cells. Visit https://www.stemcelltherjournal.org/jsctt for more groundbreaking research in this field. Key Findings…
Heighten Science Publications Inc. 